Morgan Stanley Maintains Equal-Weight on Marsh, Raises Price Target to $200

Insider Sale: CEO Dumps More Than 16,000 Shares of Financial Stock

John Q. Doyle, CEO of Marsh & McLennan Companies (MRSH), sold 16,656 shares worth approximately $3.1 million on September 2, 2026, through a pre-arranged Rule 10b5-1 trading plan. The sale represents exercised options originally granted in 2017. Following the transaction, Doyle retains approximately 117,000 shares valued at $21.94 million. The article notes that while MRSH has shown strong revenue and cash flow growth, the stock has underperformed the S&P 500 with a 3.8% CAGR versus 12.5% for the broader market, and rising net debt presents concerns.

Marsh shares are trading higher after Morgan Stanley raised its price target on the stock from $180 to $200.

Marsh Unit Marsh McLennan Agency To Acquire Independent Insurance And Advisory Firm Accel Holdings; Financial Terms Not Disclosed

The Accel Group was founded in 1936, further establishing its legacy through a strategic merger with Millhiser Smith Agency in 2018, which itself was founded in 1928. Today, the firm provides commercial and personal